U-Blot® Research Grade EnapotamabCat. No. WA2788$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EnapotamabCat. No. WA2788
U-Blot® Research Grade emzotamigCat. No. WA2787
U-Blot® Research Grade emunkitugCat. No. WA2786
U-Blot® Research Grade emugrobartCat. No. WA2785
U-Blot® Research Grade EmpasiprubartCat. No. WA2784
U-Blot® Research Grade EmirodatamabCat. No. WA2783
U-Blot® Research Grade EmiltatugCat. No. WA2782
U-Blot® Research Grade EmicizumabCat. No. WA2781
U-Blot® Research Grade EmibetuzumabCat. No. WA2780
U-Blot® Research Grade EmfizatamabCat. No. WA2779
U-Blot® Research Grade EmerfetamabCat. No. WA2778
U-Blot® Research Grade emaretamigCat. No. WA2777